Versalovic J, Osato M S, Spakovsky K, Dore M P, Reddy R, Stone G G, Shortridge D, Flamm R K, Tanaka S K, Graham D Y
Digestive Diseases, Veterans Affairs Medical Center, Houston, TX 77030, USA.
J Antimicrob Chemother. 1997 Aug;40(2):283-6. doi: 10.1093/jac/40.2.283.
Fifty-four of 59 (91.5%) clarithromycin-resistant isolates of Helicobacter pylori from different patients possessed either the A2143G (formerly A2058G) or the A2144G (formerly A2059G) mutation in the gene encoding 23S rRNA. The A2143G mutation was significantly more likely to occur in isolates with MICs exceeding 64 mg/L (65% versus 30% with the A2144G mutation; P = 0.01). The majority (26 of 31; 83.9%) of isolates with the A2143G mutation had MICs exceeding 64 mg/L. Peptic ulcer disease recurred in a substantial proportion of patients infected with H. pylori strains containing either the A2143G or the A2144G mutation.
来自不同患者的59株耐克拉霉素幽门螺杆菌分离株中,有54株(91.5%)在编码23S rRNA的基因中存在A2143G(原A2058G)或A2144G(原A2059G)突变。A2143G突变在最低抑菌浓度(MIC)超过64 mg/L的分离株中出现的可能性显著更高(65%,而A2144G突变为30%;P = 0.01)。大多数携带A2143G突变的分离株(31株中的26株;83.9%)MIC超过64 mg/L。在感染含有A2143G或A2144G突变的幽门螺杆菌菌株的相当一部分患者中,消化性溃疡疾病复发。